Truist Analyst Karnauskas holds two days of meetings with CEO Lanfear, CFO Stilwell and CCO McMichael in San Diego March 28-29.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CHRS:
- Coherus Biosciences management to meet with Truist
- Coherus Biosciences price target raised to $23 from $21 at Mizuho
- Coherus Biosciences management to meet with Mizuho
- Coherus Biosciences price target lowered to $13 from $15 at Barclays
- Coherus Biosciences price target lowered to $26 from $30 at H.C. Wainwright